Enrolling
Mapping Opportunities for HPV Vaccination and Screening Engagement and Uptake in Trans Men and Gender Non-Binary Individuals Assigned Female at Birth
Learn MoreEnrolling
Promoting Mental Health and Reducing HIV Risk Behaviours through Self-compassion, Mindful Acceptance & Resilience Transformation (SMART): An Evidence-informed Pilot Randomized Trial with Diaspora MENA Gay, Bisexual and Trans Youth in Ontario
Learn MoreReporting
Optimizing HIV prevention for sexual and gender minorities seeking mental health supports: A feasibility study
Learn MoreReporting
Barriers and Facilitators of the “Sex Now 2022” Venue-Based HIV Self-Testing and Peer-Based Linkage to Care Intervention for Sexual Minority Men, Non-Binary, and Two-Spirit People
Learn MoreCompleted
Cultural Adaptation of Gay Poz Sex (GPS): A Positive Prevention Program for Gay, HIV-Positive Latino Men in Canada and Colombia
Learn MoreEnrolling
A randomized trial of doxycycline chemoprophylaxis for the prevention of sexually transmitted infections in gay, bisexual and other men who have sex with men (gbMSM)
Learn MoreTerminated
Virtual PrEP: Rendering PrEP delivery more efficient using an mHealth intervention and TAF/FTC
Learn MoreReporting
A randomized, placebo-controlled trial of oral doxycycline for the prevention of syphilis in HIV-positive men who have sex with men (MSM)
Learn MoreOngoing
Integrating cognitive-behavioural therapy for social anxiety disorder with HIV risk reduction counselling for HIV-negative gay and bisexual men who are at high risk for HIV
Learn More
CTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.
